What is Leerink Partnrs’ Estimate for AMLX Q1 Earnings?

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Amylyx Pharmaceuticals in a report issued on Sunday, April 13th. Leerink Partnrs analyst M. Goodman anticipates that the company will post earnings per share of ($0.52) for the quarter. The consensus estimate for Amylyx Pharmaceuticals’ current […]